Literature DB >> 18974304

Prorenin and the (pro)renin receptor in ocular pathology.

Jennifer L Wilkinson-Berka1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18974304      PMCID: PMC2626371          DOI: 10.2353/ajpath.2008.080757

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  23 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Human prorenin has "gate and handle" regions for its non-proteolytic activation.

Authors:  Fumiaki Suzuki; Makoto Hayakawa; Tsutomu Nakagawa; Uddin Mohammad Nasir; Akio Ebihara; Atsushi Iwasawa; Yuichi Ishida; Yukio Nakamura; Kazuo Murakami
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

3.  Retinal neovascularization is prevented by blockade of the renin-angiotensin system.

Authors:  C J Moravski; D J Kelly; M E Cooper; R E Gilbert; J F Bertram; S Shahinfar; S L Skinner; J L Wilkinson-Berka
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

4.  Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.

Authors:  Genevieve Nguyen; Françoise Delarue; Céline Burcklé; Latifa Bouzhir; Thomas Giller; Jean-Daniel Sraer
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

5.  Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

Authors:  Atsuhiro Ichihara; Matsuhiko Hayashi; Yuki Kaneshiro; Fumiaki Suzuki; Tsutomu Nakagawa; Yuko Tada; Yukako Koura; Akira Nishiyama; Hirokazu Okada; M Nasir Uddin; A H M Nurun Nabi; Yuichi Ishida; Tadashi Inagami; Takao Saruta
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.

Authors:  Shingo Satofuka; Atsuhiro Ichihara; Norihiro Nagai; Kousuke Noda; Yoko Ozawa; Akiyoshi Fukamizu; Kazuo Tsubota; Hiroshi Itoh; Yuichi Oike; Susumu Ishida
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

7.  Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.

Authors:  A H Danser; M A van den Dorpel; J Deinum; F H Derkx; A A Franken; E Peperkamp; P T de Jong; M A Schalekamp
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

8.  Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications.

Authors:  J A Luetscher; F B Kraemer; D M Wilson; H C Schwartz; M Bryer-Ash
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

9.  Renin-containing Müller cells of the retina display endocrine features.

Authors:  J L Berka; A J Stubbs; D Z Wang; R DiNicolantonio; D Alcorn; D J Campbell; S L Skinner
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-06       Impact factor: 4.799

10.  The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.

Authors:  Christina J Moravski; Sandford L Skinner; Anthony J Stubbs; Stella Sarlos; Darren J Kelly; Mark E Cooper; Richard E Gilbert; Jennifer L Wilkinson-Berka
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

View more
  7 in total

1.  Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.

Authors:  Huifang Cheng; Xiaofeng Fan; Gilbert W Moeckel; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2011-07       Impact factor: 10.121

2.  (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation.

Authors:  Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-09-21       Impact factor: 2.557

3.  MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells.

Authors:  Rashidul Haque; Elizabeth H Hur; Annie N Farrell; P Michael Iuvone; Jennifer C Howell
Journal:  Mol Vis       Date:  2015-03-07       Impact factor: 2.367

4.  The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) -induced VEGF expression in ARPE-19 cells under a hyperglycemic condition.

Authors:  Rashidul Haque; P Michael Iuvone; Li He; Kimberly Su Chung Choi; Ashley Ngo; Samantha Gokhale; Madiha Aseem; Daniel Park
Journal:  Mol Vis       Date:  2017-04-14       Impact factor: 2.367

Review 5.  Therapeutic targets of renin-angiotensin system in ocular disorders.

Authors:  Rajesh Choudhary; Mandeep Singh Kapoor; Amrita Singh; Surendra H Bodakhe
Journal:  J Curr Ophthalmol       Date:  2016-10-20

6.  (Pro)renin Receptor-Dependent Induction of Profibrotic Factors Is Mediated by COX-2/EP4/NOX-4/Smad Pathway in Collecting Duct Cells.

Authors:  Cristian Reyes-Martinez; Quynh My Nguyen; Modar Kassan; Alexis A Gonzalez
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

7.  Inflammation in the pathogenesis of microvascular complications in diabetes.

Authors:  Dung V Nguyen; Lynn C Shaw; Maria B Grant
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-21       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.